018673888

RELINIFY

---

March 17, 2022

Trademark Summary

The trademark application RELINIFY was filed by Protagonist Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 23, 2022, and it was registered by office on August 30, 2022 without any oppositions.

The application was filed in English (Italian was selected as the second language).

Change of name and professional address of the trademark registration was recorded on August 6, 2024.

---

Goods And Services

• The mark was filed in class 5 with Pharmaceuticals and pharmaceuticals for use in the treatment of cancer and blood diseases and disorders..
• The mark was filed in class 42 with Medical research and information services with respect to pharmaceuticals, oncology, and blood diseases and disorders.